FDA Greenlights Genetic Test to Gauge Opioid Addiction Risk FDA Greenlights Genetic Test to Gauge Opioid Addiction Risk

The test will help healthcare providers to assess an individual ' s risk of developing opioid use disorder, offering a new approach to pain management.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Emergency Medicine Source Type: news